Glycogen Storage Disease Type II

Type II glycogen storage disease, also known as Pompe disease and acid maltase deficiency, is a rare autosomal recessive disorder caused by deficiency of acidic α-glucosidase (Ibrahim 1). This deficiency leads to the accumulation of glycogen in specific organs and tissues, especially the muscles, weakening the ability of it to function properly. The disease is categorized by onset time: onset of the classic infant and nonclassical late stage onset (Van Der Beek 82). Pompe disease with a Dutch pathologist Dr.

Incomplete degradation of glycogen in lysosomes is due to the lack of a single enzyme and lysosomal acid α-glucosidase causes type II glycogen storage disease (Pompe disease). 14 Liver hypertrophy and death before 2 years old due to cardiorespiratory dysfunction. There is an extreme change in clinical severity compared to the morphology of infants, often accompanied by skeletal muscle and heart involvement and a slower progressive process. A more mild form appears to be associated with low residual activity. Clinical trials of enzyme replacement therapy are ongoing

Type II glycogen storage disease, also known as Pompe disease and acid maltase deficiency, is a rare autosomal recessive disorder caused by deficiency of acidic α-glucosidase (Ibrahim 1). This deficiency leads to the accumulation of glycogen in specific organs and tissues, especially the muscles, weakening the ability of it to function properly. The disease is categorized by onset time: onset of the classic infant and nonclassical late stage onset (Van Der Beek 82). - Summary - Researchers must have viable candidate gene mutations to study gene mutations that cause Paget 's bone disease. They found the best candidate for having genetic mutations in the mouse so they transplanted genetic mutations into embryos of descendants of the mouse. Researchers hypothesized that p62P394L is sufficient to induce PDB, especially since the p62 gene is involved in the coding of a 62 kDa protein that plays a role in the signaling of osteoclast precursors.